| Everest 1953, first ascent: a clinical record. | |
| | |
MedLine Citation:
|
PMID: 12713709 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
No mountaineering expedition to Mt. Everest mounted by the Royal Geographical Society and the Alpine Club from 1921 onward reached the summit, despite the mountaineering difficulties being of a similar order to those found on the ascent of Mont Blanc (15,800 ft), the highest peak in Europe, which was first climbed in 1786. The reason for their lack of success was their inability to solve the medical and physiological problems imposed by the altitude and cold of the last thousand feet, between 28,000 and 29,028 ft. It was the solution of these problems by the Medical Research Council, backed by the Royal Society, in London, in early 1951 through 1952 that made the breakthrough leading to success in 1953. During the first ascent, in order to assess the effectiveness of these solutions, accounts were taken immediately on their descent from every climber who had been as high as the South Col (26,000 ft) or higher, including the two who had reached the summit (29,028 ft). These accounts provided a unique record and illustrated, for the first time in 30 years of Everest expeditions, how the use of adequate flow rates of supplementary oxygen when climbing, adequate supplementary oxygen when sleeping, adequate daily fluid intake, and adequate protection from the cold could transform the performance of climbers at extreme altitude from "sick men climbing in a dream" to those capable of overcoming all climatic and mountaineering obstacles. None of these advantages had been available to mountaineers of British parties of the 1920s and 1930s, nor to the Swiss expeditions in the spring and autumn of 1952, with the result that none of them was successful in reaching the summit. |
| | |
Authors:
|
Michael P Ward |
Related Documents
:
|
7089599 - Comparative studies of health care systems. 18360349 - The kappa lambda society of hippocrates: historical perspective on an early medical pro... 1105039 - The investigation of horace green. 22612299 - Medication noncompliance and patient satisfaction following percutaneous coronary inter... 12496619 - Endoscopically assisted malarplasty: one incision and two dissection planes. 18382729 - Atlantic city and the boardwalk: 1932--1976. 9785169 - Continuing medical education one year on--how was it for me? 9696519 - Prolactogenic effects of risperidone in male patients--a preliminary study. 10114819 - P & t committee rises to challenges of the changing healthcare environment. |
Publication Detail:
|
Type: Comment; Historical Article; Journal Article |
Journal Detail:
|
Title: High altitude medicine & biology Volume: 4 ISSN: 1527-0297 ISO Abbreviation: High Alt. Med. Biol. Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-04-25 Completed Date: 2003-08-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 100901183 Medline TA: High Alt Med Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 27-37 Citation Subset: IM; S |
Affiliation:
|
Society of Apothecaries of London, London, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Altitude Sickness
/
history*,
prevention & control History, 20th Century Humans Male Mountaineering / history*, physiology Nepal Oxygen / administration & dosage, history |
| Chemical | |
Reg. No./Substance:
|
7782-44-7/Oxygen |
| Comments/Corrections | |
Comment On:
|
High Alt Med Biol. 2003 Spring;4(1):25-6
[PMID:
12713708
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The ultimate source of human hematopoietic stem cells: thinking outside the marrow.
Next Document: Failure on Everest: the oxygen equipment of the spring 1952 Swiss expedition.